Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed?

YUCEL, S; AKKAYA, E; GUNTEKIN, E; KUKUL, E; DANISMAN, AHMET; Akman, SEMA; BAYKARA, MEHMET

doi:10.1016/j.urology.2004.09.036

Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed?

YUCEL S., AKKAYA E., GUNTEKIN E., KUKUL E., DANISMAN A., Akman S., ...More

UROLOGY, vol.65, no.2, pp.369-373, 2005 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 65 Issue: 2
Publication Date: 2005
Doi Number: 10.1016/j.urology.2004.09.036
Journal Name: UROLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.369-373
Akdeniz University Affiliated: Yes

Abstract

Objectives. To assess the clinical efficacy of tolterodine prescribed to children with non-neurogenic daytime urinary incontinence secondary to overactive bladder who had previously failed to improve with oral oxybutynin treatment and its relation to the side-effect profile and compliance status.